Tragara Pharmaceuticals Secures $3,261,352 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f129952a-de29-43ec-8796-fadea8394d19 - Date
11/17/2016 - Company Name
Tragara Pharmaceuticals - Mailing Address
3152 Lionshead Avenue Carlsbad, CA 92010 USA - Company Description
Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. - Website
http://www.tragarapharma.com - Transaction Type
Venture Equity - Transaction Amount
$3,261,352 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
